NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.900
-0.020 (-2.17%)
Nov 22, 2024, 4:00 PM EST - Market closed

NeuroSense Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
18111426--
Market Cap Growth
3.26%-24.68%-46.24%---
Enterprise Value
166625--
Last Close Price
0.900.791.222.46--
PB Ratio
-11.86-6.102.442.94--
P/TBV Ratio
--2.442.94--
Debt / Equity Ratio
-0.02-0.080.04---
Quick Ratio
0.450.814.1818.836.0824.68
Current Ratio
0.460.844.2819.126.3824.68
Return on Equity (ROE)
--494.83%-141.31%-66.63%-358.66%-
Return on Assets (ROA)
-150.79%-138.15%-68.90%-30.56%-208.19%-
Return on Capital (ROIC)
--339.37%-87.59%-38.61%-228.92%-
Earnings Yield
-55.91%-94.21%-73.67%-12.16%--
FCF Yield
-58.25%-78.14%-53.97%-5.87%--
Buyback Yield / Dilution
-36.48%-18.56%-84.27%-13.12%-19.10%-
Total Shareholder Return
-36.48%-18.56%-84.27%-13.12%-19.10%-
Source: S&P Capital IQ. Standard template. Financial Sources.